Last updated: July 27, 2023
Sponsor: Istituto per la Ricerca e l'Innovazione Biomedica
Overall Status: Active - Recruiting
Phase
N/A
Condition
Asperger's Disorder
Williams Syndrome
Autism
Treatment
ApisMela protocol
"Unstuck and on Target" protocol
Clinical Study ID
NCT05977075
CNR-IRIB-PRO-2023-003
Ages 7-13 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Children with diagnosis of autism and autism spectrum disorder
Exclusion
Exclusion Criteria:
- Presence of other medical disorders
Study Design
Total Participants: 12
Treatment Group(s): 2
Primary Treatment: ApisMela protocol
Phase:
Study Start date:
December 01, 2022
Estimated Completion Date:
March 31, 2024
Connect with a study center
Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
Messina, 98164
ItalyActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.